Article: Nicotinamide Riboside Boosts NAD+, to Reduce Sleep Need and Support Brain Energy: Preclinical Findings

PrevNext
Neurological Health Preclinical

Nicotinamide Riboside Boosts NAD+, to Reduce Sleep Need and Support Brain Energy: Preclinical Findings

Synopsis

Non-rapid eye movement sleep (NREMS) is linked to lower brain glucose use, which slows metabolic reactions involving NAD+. This study tested whether boosting NAD+ with nicotinamide riboside (NR) affects sleep regulation in mice. Long-term dietary NR reduced time spent in NREMS by 17% and sped up the recovery of sleep need. These results suggest that increasing NAD+ availability enhances the brain's energy capacity, reduces sleep pressure, and affects cortical activity. Overall, the study shows that NAD+ and redox metabolism play a key role in sleep homeostasis and brain function.

Journal

Sleep Advances

Share

Read more

Amyotrophic Lateral Sclerosis (ALS)

Combination Therapy with Nicotinamide Riboside, Pterostilbene, and Ibudilast Protects Motor Neurons and Prolongs Survival in ALS: Preclinical Findings

Synopsis Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease marked by oxidative stress, inflammation, and the progressive death of motor neurons. This study tested a triple t...

Read more
Metabolic Health

Nicotinamide Riboside Reverses Metabolic Dysfunction in Werner's Syndrome: Preclinical Findings

SynopsisWerner syndrome (WS) features premature aging and metabolic dysfunction, yet mechanisms remain unclear. This study found that loss of the WRN protein accelerates early fat cell formation in...

Read more